Literature DB >> 10917600

The human coronavirus 229E superfamily 1 helicase has RNA and DNA duplex-unwinding activities with 5'-to-3' polarity.

A Seybert1, A Hegyi, S G Siddell, J Ziebuhr.   

Abstract

The human coronavirus 229E replicase gene encodes a protein, p66HEL, that contains a putative zinc finger structure linked to a putative superfamily (SF) 1 helicase. A histidine-tagged form of this protein, HEL, was expressed using baculovirus vectors in insect cells. The purified recombinant protein had in vitro ATPase activity that was strongly stimulated by poly(U), poly(dT), poly(C), and poly(dA), but not by poly(G). The recombinant protein also had both RNA and DNA duplex-unwinding activities with 5'-to-3' polarity. The DNA helicase activity of the enzyme preferentially unwound 5'-oligopyrimidine-tailed, partial-duplex substrates and required a tail length of at least 10 nucleotides for effective unwinding. The combined data suggest that the coronaviral SF1 helicase functionally differs from the previously characterized RNA virus SF2 helicases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10917600      PMCID: PMC1369980          DOI: 10.1017/s1355838200000728

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  67 in total

1.  Purification, properties, and subcellular localization of foxtail mosaic potexvirus 26-kDa protein.

Authors:  M Rouleau; R J Smith; J B Bancroft; G A Mackie
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

Review 2.  Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences.

Authors:  E V Koonin; V V Dolja
Journal:  Crit Rev Biochem Mol Biol       Date:  1993       Impact factor: 8.250

3.  The "DEAD box" protein DbpA interacts specifically with the peptidyltransferase center in 23S rRNA.

Authors:  S M Nicol; F V Fuller-Pace
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

4.  Biochemical and genetic analyses of the interaction between the helicase-like and polymerase-like proteins of the brome mosaic virus.

Authors:  E K O'Reilly; N Tang; P Ahlquist; C C Kao
Journal:  Virology       Date:  1995-12-01       Impact factor: 3.616

5.  ATPase and GTPase activities associated with Semliki Forest virus nonstructural protein nsP2.

Authors:  M Rikkonen; J Peränen; L Kääriäinen
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes.

Authors:  J A Suzich; J K Tamura; F Palmer-Hill; P Warrener; A Grakoui; C M Rice; S M Feinstone; M S Collett
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  Characterization of a human coronavirus (strain 229E) 3C-like proteinase activity.

Authors:  J Ziebuhr; J Herold; S G Siddell
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Mutational analysis of vaccinia virus nucleoside triphosphate phosphohydrolase II, a DExH box RNA helicase.

Authors:  C H Gross; S Shuman
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Purification and characterization of the Upf1 protein: a factor involved in translation and mRNA degradation.

Authors:  K Czaplinski; Y Weng; K W Hagan; S W Peltz
Journal:  RNA       Date:  1995-08       Impact factor: 4.942

10.  DbpA: a DEAD box protein specifically activated by 23s rRNA.

Authors:  F V Fuller-Pace; S M Nicol; A D Reid; D P Lane
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  86 in total

1.  Biochemical characterization of the equine arteritis virus helicase suggests a close functional relationship between arterivirus and coronavirus helicases.

Authors:  A Seybert; L C van Dinten; E J Snijder; J Ziebuhr
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Coordinate replication of alfalfa mosaic virus RNAs 1 and 2 involves cis- and trans-acting functions of the encoded helicase-like and polymerase-like domains.

Authors:  A Corina Vlot; Sebastiaan M Laros; John F Bol
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 3.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 4.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

5.  Characterization of the expression, intracellular localization, and replication complex association of the putative mouse hepatitis virus RNA-dependent RNA polymerase.

Authors:  Sarah M Brockway; Corrie T Clay; Xiao Tao Lu; Mark R Denison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  Helicases as antiviral drug targets.

Authors:  David N Frick
Journal:  Drug News Perspect       Date:  2003 Jul-Aug

7.  Further identification and characterization of novel intermediate and mature cleavage products released from the ORF 1b region of the avian coronavirus infectious bronchitis virus 1a/1b polyprotein.

Authors:  H Y Xu; K P Lim; S Shen; D X Liu
Journal:  Virology       Date:  2001-09-30       Impact factor: 3.616

8.  A well-connected and conserved nucleoplasmic helicase is required for production of box C/D and H/ACA snoRNAs and localization of snoRNP proteins.

Authors:  T H King; W A Decatur; E Bertrand; E S Maxwell; M J Fournier
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

9.  Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins.

Authors:  Erik Prentice; Josephine McAuliffe; Xiaotao Lu; Kanta Subbarao; Mark R Denison
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 10.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.